Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family.
about
Tuberculosis and diabetes: current state and future perspectivesImpact of the gut microbiota on inflammation, obesity, and metabolic diseaseOverfat and Underfat: New Terms and Definitions Long OverdueNovel gene variants predict serum levels of the cytokines IL-18 and IL-1ra in older adults.Inflammation: The Common Pathway of Stress-Related Diseases.Interleukin-1β mediates macrophage-induced impairment of insulin signaling in human primary adipocytes.Plasma levels of soluble interleukin 1 receptor accessory protein are reduced in obesity.The interleukin-1 family: back to the futureAnti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.Inflammasome Activity in Non-Microbial Lung Inflammation.Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study.A single-nucleotide polymorphism in the interleukin-1 receptor-associated protein gene is associated with impaired glucose regulation and type 2 diabetes in a case-controlled study.Is interleukin-1β a culprit in macrophage-adipocyte crosstalk in obesity?A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes MellitusMaladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice.Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies.Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance.Identification of sucrose non-fermenting-related kinase (SNRK) as a suppressor of adipocyte inflammationNew insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats.Inflammation during obesity is not all bad: evidence from animal and human studies.Determinants of developing diabetes mellitus and vascular complications in patients with impaired fasting glucose.Antidiabetic potential of the heme oxygenase-1 inducer curcumin analogues.The NLRP3 inflammasome is required for the development of hypoxemia in LPS/mechanical ventilation acute lung injury.The Effects of Myo-Inositol and B and D Vitamin Supplementation in the db/+ Mouse Model of Gestational Diabetes MellitusLower NLRP3 inflammasome activity in NAG-1 transgenic mice is linked to a resistance to obesity and increased insulin sensitivity.Triactome: neuro-immune-adipose interactions. Implication in vascular biology.Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia.Interleukin-1 antagonists for diabetes.Epigenetic regulation of ASC/TMS1 expression: potential role in apoptosis and inflammasome function.Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus.Molecular and physiological roles of Pellino E3 ubiquitin ligases in immunity.Biological characteristics and agonists of GPR120 (FFAR4) receptor: the present status of research.Diabetic cardiomyopathy: role of the E3 ubiquitin ligase.Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.Inhibition of the Inflammasome NLRP3 by Arglabin Attenuates Inflammation, Protects Pancreatic β-Cells from Apoptosis, and Prevents Type 2 Diabetes Mellitus Development in ApoE2Ki Mice on a Chronic High-Fat Diet.Isoliquiritigenin Attenuates Adipose Tissue Inflammation in vitro and Adipose Tissue Fibrosis through Inhibition of Innate Immune Responses in Mice.Monacolin K and monascin attenuated pancreas impairment and hyperglycemia induced by advanced glycation endproducts in BALB/c mice.Chitinase 3-Like 1 Promotes Candida albicans Killing and Preserves Corneal Structure and Function by Controlling Host Antifungal ResponsesMetabolism and autophagy in the immune system: immunometabolism comes of age.Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice
P2860
Q26751215-5C3745DF-1237-4B67-BAB9-F25A4248FF9FQ26751430-42B09AFB-0CCB-47D3-9476-ADF2A05E5D7AQ30397621-A561DB5C-A188-4738-B32E-4995A5323CCCQ33767339-D6D11496-C447-4835-AF0F-BEC464661764Q33813364-86FEAFBA-2ACE-48F5-AE29-452520F8D04BQ34001345-28BB4A5C-D9B3-4349-8E96-DA885B57C187Q34130963-19BD80B6-D31D-4008-8676-720C708B6FE7Q34391415-097DC972-96CD-4707-B2BD-5B170E4487C8Q34444895-5D563FB0-2E0D-4C47-AAAA-F6C88D332EA5Q35020676-CF93B7C6-E54A-49AA-BB50-D5C0B43531E6Q35237821-5BF1AC83-A02E-4453-8F91-927759A89211Q35803472-3BFF4614-075C-440B-AEE9-D259A2249D6EQ35834715-672AB9B1-04C6-4E91-BF47-D2390C219520Q35941368-CF6613DB-2B32-41E1-AE51-7505EB3AF10EQ36405678-356BC67F-8AFB-444D-A841-EAFABBB2E589Q36833317-312461D6-1EAC-4B36-9F46-09B93D787379Q36932435-F214B725-06FC-4016-9722-769D7BBE09FAQ37014875-64B167B9-6243-4AEE-ACD4-1AA8974718F0Q37040345-28BD0654-4042-4702-BE86-BB247D6A2DF1Q37174503-5BB1473F-6E72-465F-8E9B-5165FBABB94CQ37201691-D2534AA0-C55E-417A-91B9-65AABF616E89Q37244395-B29FC293-99F9-4781-8F3C-676F30F52BAEQ37596140-13E7DB19-1548-4FEA-BEC5-957436D6AF65Q37673227-5540B4DD-DDCC-4A7A-BB7E-F09159D282E1Q37695121-25934783-750D-42CE-89D5-DC485FEDF0F2Q37702548-82DFBAAA-CB07-460B-B5AE-336442D7A3FCQ37723991-C534863D-D248-4EE1-998D-3D1FE1F29B11Q38109212-63D2BD50-CB5E-49F9-A5E6-E5FFAE8C0D49Q38167273-8ED1AF21-5EBA-40D6-8FD8-BB6793D29814Q38363794-FEF8AEBF-B5F2-42CE-8203-AD20B687A27AQ38530624-0BC57FC9-6F21-45FD-A482-4E93281D9AA8Q38558377-620295A0-0B75-4AB4-B867-6E12575EBAE1Q38687425-545F7D02-8493-4EF1-AE09-0A647D804DB4Q38698442-AE72D458-CD1A-413E-84B7-90F2E6086FB7Q38780750-551AFB1E-0C85-4FD2-ADAF-D45789C5DB49Q38997642-276291CE-A37E-4DE1-86A5-CF8B8E1C0F69Q39327224-8B560F9C-2694-4FDD-806D-232AD3BF6C50Q41074464-0CFBB4FC-BA87-4E72-B64B-3C0437922F05Q42057513-412FE411-D9C6-40F9-B189-890F94EC9F0DQ42361197-0667AC27-8C13-4E08-8F96-78EB53DADCAD
P2860
Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inflammation links excess fat ...... e of the interleukin-1 family.
@en
type
label
Inflammation links excess fat ...... e of the interleukin-1 family.
@en
prefLabel
Inflammation links excess fat ...... e of the interleukin-1 family.
@en
P2093
P2860
P921
P1476
Inflammation links excess fat ...... e of the interleukin-1 family.
@en
P2093
Cees J Tack
Leo A B Joosten
Mihai G Netea
Rinke Stienstra
P2860
P304
P356
10.1111/J.1600-065X.2012.01145.X
P577
2012-09-01T00:00:00Z